⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 4, 2024Open Access

Supplemental Figure S6 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer

Adrianne Wallace-Povirk Carrie O’Connor Aamod S. Dekhne Xun Bao Md. Junayed Nayeen Mathew Schneider Jade M. Katinas Jennifer Wong-Roushar Seongho Kim Lisa Polin Jing Li Jessica B. Back Charles E. Dann Aleem Gangjee Zhanjun Hou Larry H. Matherly

View Full Paper

Ask AI

Bookmark

Share

Abstract

This figure shows purine nucleotides in SKOV3 EOC cells treated with pyrrolo[3,2-d]pyrimidine antifolates.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wallace-Povirk et al. (2024) studied this question.

synapsesocial.com/papers/68e664bab6db6435875f14f2 https://doi.org/10.1158/1535-7163.25964881.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Figure S6 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024
2Supplemental Figure S5 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024
3Supplemental Figure S5 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024
4Supplemental Figure S2 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024
5Supplemental Figure S2 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer2024